These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 9626023)
1. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Cryer B; Feldman M Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Famaey JP Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series. Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959 [TBL] [Abstract][Full Text] [Related]
6. Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. Fenner H Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):28-33. PubMed ID: 9219317 [TBL] [Abstract][Full Text] [Related]
7. Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Blain H; Boileau C; Lapicque F; Nédélec E; Loeuille D; Guillaume C; Gaucher A; Jeandel C; Netter P; Jouzeau JY Br J Clin Pharmacol; 2002 Mar; 53(3):255-65. PubMed ID: 11874389 [TBL] [Abstract][Full Text] [Related]
8. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Muscará MN; McKnight W; Asfaha S; Wallace JL Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192 [TBL] [Abstract][Full Text] [Related]
9. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis. Sawdy R; Pan H; Sullivan M; Bennett P J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850 [TBL] [Abstract][Full Text] [Related]
10. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Ehrich EW; Dallob A; De Lepeleire I; Van Hecken A; Riendeau D; Yuan W; Porras A; Wittreich J; Seibold JR; De Schepper P; Mehlisch DR; Gertz BJ Clin Pharmacol Ther; 1999 Mar; 65(3):336-47. PubMed ID: 10096266 [TBL] [Abstract][Full Text] [Related]
12. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood. van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130 [TBL] [Abstract][Full Text] [Related]
13. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. Streppa HK; Jones CJ; Budsberg SC Am J Vet Res; 2002 Jan; 63(1):91-4. PubMed ID: 16206787 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series. Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960 [TBL] [Abstract][Full Text] [Related]
16. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Kay-Mugford P; Benn SJ; LaMarre J; Conlon P Am J Vet Res; 2000 Jul; 61(7):802-10. PubMed ID: 10895904 [TBL] [Abstract][Full Text] [Related]
17. In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats. Laudanno OM; Cesolari JA; Esnarriaga J; San Miguel P; Bedini OA Dig Dis Sci; 2000 Jul; 45(7):1359-65. PubMed ID: 10961715 [TBL] [Abstract][Full Text] [Related]
18. [NSAIDs caused gastric mucosal injury: with a special reference to COX-2]. Sakamoto C J Nippon Med Sch; 2003 Feb; 70(1):5-11. PubMed ID: 12646969 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Giuliano F; Warner TD Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826 [TBL] [Abstract][Full Text] [Related]
20. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats]. Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]